Cobitolimod Market Size and Forecast Cobitolimod, an investigational drug for moderate-to-severe ulcerative colitis (UC), targets the substantial unmet need in patients who fail conventional treatments. As a Toll-like receptor 9 (TLR9) agonist,…
Anx Fasedienol Market: Size, Forecast, Drivers, and Key Trends
Fasedienol Market Size and Forecast As an investigational drug, Fasedienol (PH-94B) currently does not hold a market size, but its potential is tied to the vast and growing anxiety disorders market, particularly…
Dep Gepirone Market: Size, Forecast, Drivers, and Key Trends
Gepirone Market Size and Forecast Gepirone (marketed as Exxua) is an extended-release formulation recently approved by the FDA in October 2023 for the treatment of Major Depressive Disorder (MDD). Its market introduction…
HF CVOT Data Drugs Market: Size, Forecast, Drivers, and Key Trends
HF CVOT Data Drugs Market Size and Forecast The global Heart Failure (HF) drugs market, particularly those supported by Cardiovascular Outcome Trial (CVOT) data, is a critical segment showing rapid expansion. The…
AF Abelacimab Market: Size, Forecast, Drivers, and Key Trends
AF Abelacimab Market Size and Forecast Abelacimab is an investigational fully-human monoclonal antibody targeting Factor XI and Factor XIa, currently in Phase 3 trials for stroke prevention in atrial fibrillation (AF). The…
HTN BBI-589 Market: Size, Forecast, Drivers, and Key Trends
HTN BBI-589 Market Size and Forecast HTN BBI-589 is anticipated to enter a highly competitive global market for hypertension treatments, a segment valued at billions of dollars annually due to the massive…
Hyperchol Olpasiran Market: Size, Forecast, Drivers, and Key Trends
Olpasiran Market Size and Forecast Olpasiran is an investigational small interfering RNA (siRNA) therapy developed by Amgen, targeting lipoprotein(a) or Lp(a) levels. It is being studied for patients with established atherosclerotic cardiovascular…
NAFLD VK2809 Market: Size, Forecast, Drivers, and Key Trends
NAFLD Market and VK2809 Forecast The Non-Alcoholic Fatty Liver Disease (NAFLD) market is significant, valued at USD 2.01 billion in 2024, and is projected to reach USD 3.808 billion by 2035 with…
T1D Lantidra Market: Size, Forecast, Drivers, and Key Trends
Lantidra Market Size and Forecast Lantidra (donislecel) represents a specialized, high-value segment within the Type 1 Diabetes (T1D) therapeutic market, specifically targeting adults who struggle with severe hypoglycemia despite intensive management. As…
pJIA Sarilumab Market: Size, Forecast, Drivers, and Key Trends
Polyarticular Juvenile Idiopathic Arthritis (pJIA) Sarilumab Market Size and Forecast The market for Sarilumab in pJIA is nascent but poised for growth, following its recent FDA approval for patients weighing 63kg or…